期刊文献+

2型糖尿病大鼠早期认知功能改变及海马磷酸化N-甲基-D-天冬氨酸受体2B亚基、Wnt3a和去整合素金属蛋白酶10表达的研究 被引量:3

Early changes of cognitive function in type 2 diabetes rat and expression of p-NR2B,Wnt3a and ADAM10 in hippocampus
原文传递
导出
摘要 目的观察T2DM大鼠早期认知功能改变及海马磷酸化N-甲基-D-天冬氨酸受体2B亚基(p-NR2B)、Wnt3a和去整合素金属蛋白酶10(ADAM10)的表达变化。方法将40只健康雄性SD大鼠采用随机数字表法分为对照组(Con,n=20),糖尿病组(DM,n=20)。Con组以普通饲料喂养8周后单次空腹腹腔注射柠檬酸缓冲液。DM组以高脂高糖喂养8周诱导IR后腹腔小剂量注射STZ 35mg/kg,3d后测血糖,血糖≥16.7mmol/L确诊T2DM。造模成功后10、20d分别通过Y迷宫、八臂迷宫检测认知功能改变,17、21、28d取大鼠海马,Western blot测定海马p-NR2B、Wnt3a和ADAM10的表达。结果与Con组比较,DM组在Y迷宫自发活动次数为(6.9±3.2)次,自主选择率(SA%)为(42.2±29.5)%,差异有统计学意义(P<0.05);DM组在八臂迷宫的1、3、6d测试时间分别为(459.2±143.5)s、(357.3±131.7)s、(274.0±145.1)s,较Con组延长(P<0.05),记忆错误(WME)、参考记忆错误(RME)和总记忆错误(TE)比较,差异无统计学意义(P>0.05)。与Con组比较,DM组各时间点海马中p-NR2B、Wnt3a和ADAM10的表达降低(P<0.05)。结论T2DM大鼠海马中p-NR2B、Wnt3a和ADAM10的表达减少可能参与其早期认知功能的下降。 Objective To investigate the early changes of cognitive function in rats with type 2 diabetes (T2DM) and the expression of FNR2B,Wnt3a and ADAM10. Methods A total of 40 healthy male SD rats were divided into two groups according to the random number method: control group (Con,n =20),diabetes mellitus group (DM, n=20). Con group were fed on normal diet for 8 weeks, and then injected intraperitoneally with citrate buffer. DM group were fed on high fat and high glucose diet for 8 weeks to induce insulin resistance (IR) and injected intraperitoneally with streptozotocin (STZ) 35 mg/kg. T2DM were diagnosed when blood glucose level ≥16.7 mmol/L after 3 days. The changes of cognitive function were evaluated via Y maze and eight-arm radial maze in the 10^th day and 20^th days of the established model rats. The expression of hippocampal p-NR2B,Wnt3a and ADAM10 were measured by Western blot on the 17^th day, 21^th day, and 28^th day. Results Locomotor activity counts (6.9 ± 3.2) times in DM group and the percentage of spontaneous alternation (42.2 ± 29.5)% in DM group were significant different between Con and DM group(P〈0.05). The finishing time in I d, 3 d and 6 d of eight- arm radial maze were significantly higher in DM group(459.2 ± 143.5) s, (357.3 ± 131.7) s, (274.0 ± 145. ls)than in Con group(P〈0.05). There were no significant differences in WME,RME or TE between the two groups (P〈0.05). The expression of p-NR2B,Wnt3a and ADAM10 in hippocampus were down- regulated at each day point in DM group than in COn group (P〈 0. 05). Conclusion The down- regulation of p-NR2B, Wnt3a and ADAM10 in the hippocampus may be involved in the reduced cognitive function in rats with T2DM.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2018年第2期150-155,共6页 Chinese Journal of Diabetes
基金 国家自然科学基金(81073125)
关键词 糖尿病 2型 海马 N-甲基-D-天冬氨酸受体2B亚基 WNT3A 去整合素金属蛋白酶10 认知 Diabetes mellitus, type 2 Hippocampus NR2B protein Wnt3a protein ADAM10 Cog-nition
  • 相关文献

参考文献1

二级参考文献7

  • 1Nicolas Cherbuin,Perminder Sachdev,Kaarin J. Anstey.Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study[J].Neurology.2012(10)
  • 2Shayna A. Wrighten,Gerardo G. Piroli,Claudia A. Grillo,Lawrence P. Reagan.A look inside the diabetic brain: Contributors to diabetes-induced brain aging[J].BBA - Molecular Basis of Disease.2008(5)
  • 3Christopher T. Kodl,Elizabeth R. Seaquist.Cognitive Dysfunction and Diabetes Mellitus[J].Endocrine Reviews.2008(4)
  • 4Geert Jan Biessels,Salka Staekenborg,Eric Brunner,Carol Brayne,Philip Scheltens.Risk of dementia in diabetes mellitus: a systematic review[J].Lancet Neurology.2006(1)
  • 5Dr. Malaz Boustani MD, MPH,Christopher M. Callahan MD,Frederick W. Unverzagt PhD,Mary G. Austrom PhD,Anthony J. Perkins MS,Bridget A. Fultz MA,Siu L. Hui PhD,Hugh C. Hendrie MB, ChB.Implementing a screening and diagnosis program for dementia in primary care[J].Journal of General Internal Medicine.2005(7)
  • 6C Enzinger,F Fazekas,P M. Matthews,S Ropele,H Schmidt,S Smith,R Schmidt.Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects[J].Neurology.2005(10)
  • 7Kate V. Allen,Brian M. Frier,Mark W.J. Strachan.The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations[J].European Journal of Pharmacology.2004(1)

共引文献21

同被引文献33

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部